Anticholinergic burden in middle and older age is associated with lower cognitive function, but not with brain atrophy. (2023)
Attributed to:
Sharing the diagnosis of dementia in the post-Covid clinic: patient and practitioner perspectives
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.15698
PubMed Identifier: 36813260
Publication URI: http://europepmc.org/abstract/MED/36813260
Type: Journal Article/Review
Volume: 89
Parent Publication: British journal of clinical pharmacology
Issue: 7
ISSN: 0306-5251